Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream healthcare has faced significant hurdles. While private clinics have provided access to cannabis-based medicines (CBMPs), many healthcare professionals remain sceptical, largely due to outdated perceptions, limited clinical education, and a lack [...]
A new research partnership between the University of Malta and the Authority for the Responsible Use of Cannabis will study the differences between illegal cannabis and that which is accessed through licensed associations. The agreement, which will see the University of Malta and the ARUC collaborate [...]
Europe’s first patient-led event will return next month with a focus on the medicinal use of cannabis in chronic neurodegenerative diseases. Following a successful launch in Madrid in October, We, The Patients, will host its first event in Switzerland on 1 March at the Resident Zürich [...]
Via Business of Cannabis Spain’s long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been sent to the European Union for approval. If approved, this should give Spanish patients legal access to medical cannabis for the first [...]
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van Heerden, a clinical doctor at Releaf with a background in emergency medicine, believes medical cannabis should be considered a first-line treatment option rather than an alternative. The Opioid Crisis: Over 500,000 [...]
New findings, from the largest study of its kind, suggest cannabis use may be linked to a decline in working memory among young adults. The new study published in JAMA Network Open explores the effects of both recent and lifetime cannabis use on brain function during [...]
Via Business of Cannabis The first parliamentary debate on medical cannabis in the UK under the new Labour administration has shattered hopes of a more progressive stance on reform. Despite impassioned speeches from members of various parties, unanimously calling for the UK’s ‘patchwork’ cannabis regulation to [...]
Canadian researchers have developed a unique method to allow for standardized cannabis dosing among different consumption methods. Researchers at UBC Okanagan have created an Index of Cannabis Equivalence (ICE), a unique approach to standardized cannabis dosing across different consumption methods. Published in the Journal of Psychoactive [...]
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and addressing long-standing issues in medical cannabis access. Starting July 2025, the sale of low-THC cannabis and [...]
UK brand, HEMPE, has secured NSF certification for its CBD gel, giving it the green-light for use among professional athletes and military personnel. The Dorset-based brand was founded by former boyband star and commando, Farard Darver, following an injury in Afghanistan. HEMPE’S CBD gel is now [...]
The airline Jet2 has apologised to a medical cannabis patient—and is said to be ‘reviewing its policies’—after their medication was confiscated on a flight from Belfast. David Toms from Belfast, who is prescribed cannabis-based medicines for chronic pain and anxiety, was flying to Antalya in Turkey [...]
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp. Ocean Development (Dorset) Ltd. and connected retail business CBD Flower Shop Ltd. are seeking damages from the Home Office amid allegations of ‘unlawful [...]
Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report. The research, commissioned by charity Medan Family Foundation, reveals almost 400 families are sourcing illegal cannabis products from drug [...]
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks. Curaleaf International has successfully registered three separate oil-based products in the country, which legalised medical cannabis last August. While it will be the first [...]
A new study has investigated changes in opioid use in US states which have passed medical and recreational cannabis laws. The study, led by Columbia University Mailman School of Public Health, found no changes in opioid outcomes among the general population following the states’ passage of [...]
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by the Centre for Addiction and Mental Health (CAMH) in Canada, sheds light on the ethical complexities [...]
Inflammatory bowel disease (IBD) patients in the UK have reported improvements in their condition following treatment with medical cannabis. According to observational data published in the journal Expert Review of Gastroenterology & Hepatology, medical cannabis treatment was associated with sustained improvements in health-related quality of life [...]
New preliminary research highlights the potential of Ayurvedic medicine combined with medical cannabis as an alternative treatment for menstrual cramps. Results from a Phase 1 clinical trial have found ‘strong preliminary evidence’ to support the safety and efficacy of a new patent-pending formulation in the management [...]
Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months. Amid the continued political chaos in the country, participants in France’s medical cannabis ‘experiment,’ which is now entering its fifth year, faced an [...]
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly following the regulatory changes in Germany. Ukraine’s Health Minister, Viktor Liashko, visited Germany this year as [...]
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes and policy. It was a year dominated by elections, with around half of the world’s population [...]
In a new study researchers explored whether CBD can reduce scan-related anxiety in patients with advanced breast cancer. The findings showed that while CBD did not significantly change scan-related anxiety when compared to a placebo, it was safe and resulted in significantly lower overall anxiety levels [...]
Via Business of Cannabis French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment comes to an end with no next steps in place. The French Society for the Study and Treatment of Pain (SFETD) issued [...]
From April 2025, Dutch coffee shops will only be permitted to sell regulated cannabis products, as the next phase of the country’s adult-use pilot gets underway. One year on from the launch of the Netherlands’ Closed Coffee Shop Chain Experiment, regulators have set a fixed date [...]
Jazz Pharmaceuticals has shared new data to support the efficacy of Epidiolex in patients with tuberous sclerosis complex (TSC). Research shared at the American Epilepsy Society (AES) 2024 Annual Meeting held from 6-10 December in Los Angeles, California supports the use of Epidiolex in the treatment [...]
MAPS (Multidisciplinary Association for Psychedelic Studies) has secured FDA clearance to conduct a clinical trial examining the use of smoked cannabis for the treatment of PTSD symptoms among veterans. After three years of negotiation, the FDA has given MAPS the green light to carry out a [...]
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year. While this announcement comes nearly seven years after the novel [...]
Thousands more doctors in the Czech Republic will soon be permitted to prescribe medical cannabis under a new decree published by the Ministry of Health. From April 2025, the country’s 5,000 general practitioners will be permitted to prescribe medical cannabis to patients with chronic pain, following [...]
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds. Last month, Business of Cannabis reported that two long-awaited NHS clinical trials to [...]
Researchers from the Centre for Reproductive Health at the University of Edinburgh have co-authored a new review paper highlighting the potential of CBD in the treatment of endometriosis. The new paper, published in the top-ranking journal Trends in Pharmacological Science (TIPS), finds that CBD is a [...]
A newly-obtained report by France’s Directorate General of Health (DGS) evaluating the impact of the medical cannabis pilot, recommended the roll out of a temporary regulatory framework last year. The Union of Industrialists for the Valorization of Hemp Extracts (UIVEC) in France says the report, dated [...]
Representatives from five European countries, as well as the European Union Drug Agency (EUDA), met in Germany last week to discuss the regulation of cannabis for non-medical purposes. European leaders from Luxembourg, Malta, the Netherlands and Czech Republic attended an international ministerial exchange in Germany to [...]
Via Business of Cannabis Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week. The Danish pilot scheme has been running since 2018, and has continued to expand in both scope and [...]
Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer term plans to phase out flower-based products altogether. As of January 2025, patients in Luxembourg will no longer be able to access cannabis flower containing high levels [...]
New research has found no association between long-term cannabis use and cognitive decline in later life. Longitudinal data published in the journal Brain and Behavior, found no significant harmful effects of cannabis use on age-related cognitive decline. Researchers in Denmark examined the relationship between lifetime cannabis [...]
Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain territory. On [...]
Lifetime cannabis use is associated with several changes in brain structure and function in later life, suggests an observational study, but these associations may not be causal. This is according to researchers who conducted a genetic analysis of data from over 15,000 cannabis consumers in the [...]
A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep without any intoxicating effects. Research by scientists at the University of Sydney is the first to use objective measures to show the component, known as cannabinol (CBN), increases sleep in [...]
Six years on from the legalisation of medical cannabis in the UK, families have made a fresh call for NHS access, as new figures reveal lack of prescribing. Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, [...]
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation. Established earlier this year to further scrutinise the recommendations of the Citizens Assembly, the specialist committee was given until [...]
New findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use over the last decade. The study, published in the journal Pediatric Reports, reveals that in 2011, 23.1% of adolescents indicated they were current users, but by 2021, this figure [...]
Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public. Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their personal experiences and [...]
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the numbers [...]
Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University of York. Researchers [...]
The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of thousands of euros [...]
UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly 100 clinical trials, real-world studies, and [...]
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. [...]
By Sarah Sinclair with additional reporting from Ben Stevens (Business of Cannabis) Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first promised in [...]
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of [...]
Ukraine’s Ministry of Health has approved the draft list of conditions for which medical cannabis can now be prescribed, excluding PTSD and other mental health disorders until more research is available. The impact of trauma and PTSD following Russia’s invasion of Ukraine played a key role [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
